Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Gain Therapeutics, Inc.

NASDAQ: GANX · Life Sciences · 5 alerts · CIK 1819411

Share price
$0.9402Close, Nov 16
Market cap
$41.9M
Shares outstanding
44.53MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Gain Therapeutics, Inc. filings on SEC EDGAR ↗

4:31 PM ET 8-K
Leadership Change

Gain Therapeutics Leadership Change

Gianluca Fuggetta resigned as Senior Vice President of Finance, principal financial officer, and principal accounting officer effective September 30, 2026. Gene Mack, the company's current President and CEO, has been appointed to serve as interim Chief Financial Officer effective October 1, 2026, while the company searches for a permanent replacement.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.